Dr Suresh Muthukumarasway is currently an Associate Professor in psychopharmacology at The University of Auckland.

Suresh started studying psychedelic drugs in 2011, collaborating with Professor David Nutt and Dr Robin Carhart-Harris, investigating the electrophysiology of psilocybin. Since then he has been involved in neuroscience studies of LSD, ketamine, DMT and ayahuasca. His research group is soon to start the first placebo controlled study of LSD microdosing, where participants will be allowed to take LSD at home on prescription.

Written by